Lv1
10 积分 2025-03-18 加入
Micronuclei and Cancer
3小时前
已完结
FANCM promotes PARP inhibitor resistance by minimizing ssDNA gap formation and counteracting resection inhibition
4小时前
已完结
Choriocarcinoma in mother and fetus
2天前
已完结
AMPK: restoring metabolic homeostasis over space and time
17天前
已完结
Preclinical evaluation of olaparib and metformin combination in BRCA1 wildtype ovarian cancer
17天前
已完结
AMP-activated protein kinase is a positive regulator of poly(ADP-ribose) polymerase
17天前
已关闭
AMPK Interactome Reveals New Function in Non-homologous End Joining DNA Repair
17天前
已关闭
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
18天前
已完结
Overall Survival and the Evolving Benefit-Risk Assessment for Poly (ADP-ribose) Polymerase Inhibitors in Advanced Ovarian Cancer
27天前
已关闭
Adjuvant Chemoradiotherapy vs Radiotherapy Alone for Patients With Intermediate-Risk Cervical Cancer
28天前
已完结
皖公网安备34019202002308
